The FDA says esketamine, an antidepressant derived from the anesthetic and party drug ketamine, can now be prescribed on its ...

Spravato is now the first-ever stand-alone therapy for treatment-resistant depression, and is on its way to becoming a ...

The global effervescent tablet market size is estimated to grow by USD 4.80 billion from 2024 to 2028, according to Technavio ...

We have yet to find the cure for cancer, but there are ways to treat the disease and mitigate your risk of dying from it - ...